Skip to main content

Table 1 Patient Characteristics

From: Is nebulized saline a placebo in COPD?

  Active group Placebo group
Gender 13 Male, 7 Female 12 Male, 8 Female
Age (Mean, SD) 68.1 +/- 7.2
Range 54–79
67.3 +/- 7.4
Range 58–79
Mean FEV1
95% CI
0.77 Litres
0.65–0.89
0.78 Litres
0.61–0.95
FEV1 as % predicted (Mean and SD) 29.9 (10.0) 30.6 (14.8)